Lv73
3450 积分 2023-08-23 加入
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance
6天前
已完结
PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor
1个月前
已完结
Peripheral T cell expansion predicts tumour infiltration and clinical response
1个月前
已完结
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody
1个月前
已完结
Reconstitution of an Anti‐HER2 Antibody Paratope by Grafting Dual CDR‐Derived Peptides onto a Small Protein Scaffold
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
2个月前
已完结
Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
2个月前
已完结
Current landscape of CD3 bispecific antibodies in hematologic malignancies
2个月前
已完结
Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignancies
2个月前
已完结
皖公网安备34019202002308
